6/20/2018
`
`A-498 ATCC ® HTB-44 ™ Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44 TM)
`Organism: fiQmQ...$apiens,..llli!nJill I Tissue: kidney Disease: carcinoma
`
`GENERAL INFORMATION
`
`.',Ol ·',.,,.~ •. ,•.(cT,,· '.·'",. ·•--1·1,•.,· c. 1-
`'"n '" ~ -
`~
`
`-..:' ~
`
`,
`
`CULTURE ME1'HCD
`
`SPE.C!HCATION'S I H~STORY I DOC! j~1f.:NTA.TH)N
`
`- ,
`
`·1
`
`··1
`
`SHARE I EMAIL i PRINT
`I
`:
`I
`:
`
`Permits and Restrictions
`
`Vlow Porrnits
`
`Organism
`
`Tissue
`
`Product Format
`
`Homo sapiens, human
`
`kldnoy
`
`frozen
`
`Morphology
`
`epithelial
`
`Culture Properties
`
`adherent
`
`Blosafety Level
`
`Biosafety classlflca/1011 Is based 011 U.S. Pubflc Health Service
`~ .. It is the responslbflity of tho customer to ensure that
`thoir facilities comply with blosafety regulations for their own
`
`Disease
`
`Age
`
`Gender
`
`country.
`
`carcinoma
`
`52 years
`
`female
`
`Storage Conditions
`
`liquid nitrogen vapor phase
`
`h tps://www.atcc.org/Products/AII/HTB-44.aspx?&p=1 &rel=generalinformatlon#generalinformation
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 1
`
`
`
`A-498 ATCC ® HTB-44 ™ Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44 TM)
`Organism: fiQmQ...$apiens,..llli!nJill I Tissue: kidney Disease: carcinoma
`
`GENERAL INFORMATION
`
`.',Ol ·',.,,.~ •. ,•.(cT,,· '.·'",. ·•--1·1,•.,· c. 1-
`'"n '" ~ -
`~
`
`-..:' ~
`
`,
`
`CULTURE ME1'HCD
`
`SPE.C!HCATION'S I H~STORY I DOC! j~1f.:NTA.TH)N
`
`- ,
`
`·1
`
`··1
`
`SHARE I EMAIL i PRINT
`I
`:
`I
`:
`
`Permits and Restrictions
`
`Vlow Porrnits
`
`Organism
`
`Tissue
`
`Product Format
`
`Homo sapiens, human
`
`kldnoy
`
`frozen
`
`Morphology
`
`epithelial
`
`Culture Properties
`
`adherent
`
`Blosafety Level
`
`Biosafety classlflca/1011 Is based 011 U.S. Pubflc Health Service
`~ .. It is the responslbflity of tho customer to ensure that
`thoir facilities comply with blosafety regulations for their own
`
`Disease
`
`Age
`
`Gender
`
`country.
`
`carcinoma
`
`52 years
`
`female
`
`Storage Conditions
`
`liquid nitrogen vapor phase
`
`h tps://www.atcc.org/Products/AII/HTB-44.aspx?&p=1 &rel=generalinformatlon#generalinformation
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 1
`
`
`
`6/20/2018
`
`A-498 ATCC ® HTB-44 TM Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44 ™)
`Organism: Homo sa~,J:u!Jru!n I Tissue: .!ill!ru:!Y / Disease: carcinoma
`
`SHARE EMAIL i PRINT
`i
`
`Derivation
`
`Clinical Data
`
`Tumorlgenlc
`
`Effects
`
`Commonts
`
`S. Aaronson isolated this line using techniques as described for
`ATCC HTB-41.
`
`ferna!e
`
`Yos
`
`Yes, in nude mice; forms undifferentiated carcinoma; also forms
`tumors In anti thymocyte serum treatBd newborn mice
`
`https:/ /www.alee.org/Products/ All/HT B-44. aspx? &p= 1 &rel =characteristics#characteristics
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 2
`
`
`
`6/20/2018
`
`A-498 ATCC ® HTB-44 rM Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44™)
`Organism: ~IUQl!.£,..hllinJ!n I Tissue: .!lli!rulY. I Disease: carcinoma
`' CHARACT[R,:H!Ui ! CULTURE METHOD
`
`-----... - ... -
`nFNl'' fo\L ,;,FORMAT,Ocl
`
`r
`
`- - - ···- 1
`
`l
`
`{iPECIFICATONS
`
`SHARE : EMAIL ! PRINT
`
`Complete Growth Medium
`
`The base medium for this cell lino is ATCC-formulated Eagle's
`Minimum Essential Medium, Catalog No. 30-2003. To make the
`complete growth medium, add !11<, following components to the
`base medium: fetal bovine serum to a final concentration of 10%.
`
`Subculturing
`
`1. Remove and discard culture medium.
`
`2. Briefiy rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM
`EDTA solution to removo all traces of serum which contains
`trypsin inhibitor.
`
`3. Add 2.0 to 3.0 mL ofTrypsin-EDTA solution to fiask and
`observe cells under an Inverted microscopH until cell layer is
`dispersed (usually within 5 to Hi minutes).
`Note: To avoid clumping do 1101 agitate the cells by hitting or
`shaking the, fiask while waiting for the cells to detach. Cells
`that are difficult to detach may be placed at 37'C to facilitate
`dispersal.
`
`4. Add 6.0 to 8.0 ml of complete growth medium and aspirate
`cells by gently pipetting.
`
`5. Add appropriate aliquots of the cell suspension to new culture
`vessels.
`
`6. Incubate culturns at 37'C.
`
`Subcultivatlon Ratio: A subcullivatlon ratio of 1 :3 to 1 :8 Is
`recommended
`Medium Renewal: Twice per week
`
`Cryopreservatlon
`
`Freeze medium: culture rnediurn, 95%; DMSO, 5%
`Storage temperature: liquid nitrogen vapor phase
`
`Culture Conditions
`
`Atmosphere: air, 95%; carbon dioxide (CO2), 5%
`Temperature: 37'C
`
`https://www.atcc.org/Products/AII/HTB-44 .aspx?&p=1&rel=cu l1uremethod#culturemethod
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 3
`
`
`
`6/20/20 18
`
`A-498 ATCC ® HTB-44 rM Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44 TM)
`Organism: /jQJJJ_Q_J,apiens, human / Tissue: kidney / Disease: carcinoma
`
`SPECIFICATIONS
`
`SHARE EMAIL PRINT
`
`STR Profllo
`
`lsoenzymes
`
`Amologonin: X
`CSF1PO: 1·1,12
`D13S317: 12
`D168539: 12
`D5S818: 11 ,13
`D7S820: 10,11
`TH01: 6,9.3
`TPOX: 8,11
`vWA: 18
`
`AK-1, 1
`ES-D, 2
`G6PD, B
`GL0-I,2
`Mo-2, 1
`PGM1, 1-2
`PGM3, 1
`
`https://www.atcc.org/Products/AII/HTB-44.aspx?&p=1&rel=specifica!ions#specifications
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 4
`
`
`
`6/20/2018
`
`A-498 ATCC ® HTB-44 TM Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44™)
`
`Organism: Homo sapiens, human / Tissue: ~Y / Disease: carcinoma
`
`I ,;ENEfl'\' 1NfCF.C1{,7' C':
`
`Namo of Depositor
`
`W Nelson-Floes
`
`Doposited As
`
`iiomo sapiens
`
`SPFC!!"' !C.\Tln\;B
`
`HISTORY
`
`SHARE ' EMAIL ' PRINT
`I
`I
`
`References
`
`Fogh J, et al. Absence of Hela cell contamination In 169 cell lines
`derived from human tumors. J. Natl. Cancer Inst. 58: 209-214,
`1977. PubMed: ~
`
`Goodfellow M, et al. One hundred and twcmty-soven cultured
`human tumor cell lines producing tumors in nude mice. J. Natl.
`
`Cancer Inst. 59: 221-226, 1977. PubMed: I7210034
`
`Faust JB, Meokor TC. Amplification and oxprossion ot tho bcl-1
`
`gene in human solid tumor cell lines. Cancer Res. 52: 2460-2463,
`
`1992. PubMed: 1568216
`
`Giard DJ, et al. 1n vitro cultivation of human tumors:
`establishment of cell lines derived from a series of solid tumors. J.
`Nall. Cancer Inst. 51: 1417-1423, 1973. PubMed: 4357758
`
`Fonh J. Cultivation, characterization, and identification of human
`tumor cells wlt11 emphasis on kidney, testis, and bladder tumors.
`Natl. Cancer Inst. Monogr. 49: 5-9, 1978. PubMed: 571047
`
`htlps://www.atcc.org/Products/AII/HTB-44.aspx?&p=1 &rel=history#history
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 5
`
`
`
`6/20/2018
`
`A-498 ATCC ® HTB-44 TM Homo sapiens kidney carcinoma
`
`A-498 (ATCC® HTB-44 ™)
`Organism: ~~,..hilln.an / Tissue: !ill!ru!Y. / Disease: carcinoma
`
`Permits
`
`Theso permits may bo required for shipping this product:
`
`DOCUMENTATION
`
`SHARE . EMAIL : PRINT
`
`Basic Documentation
`
`References
`
`CustorrMrs located in the stat<1 of Hawaii wlll neod to contact
`t11e Hawaii Depa11ment of Agriculture to determine if an Import
`Permit is required. A copy of the permit or documentation that
`a permit is not required must be sent to ATCC in advance of
`sl1ipment.
`
`8
`
`Product Sheet Certificate of Analysis
`
`SDS
`
`Fogh J, et al. Absence of Hela cell contamination In 169 cell lines
`derived frorn hurnan tumors. J. Natl. Cancer Inst. 58: 209 .. 214,
`1977. PubMod: 833871
`
`Goodfollow M, et al. Orlfl hundred and twenty-soven cultured
`
`human tumor coll lines producing tumors in nude mice. ,I. Natl.
`
`Cancer Inst. 59: 221-226, 1977. PubMed: 77210034
`
`Faust Jl3, Meeker TC. Amplification and expression of the bcl-1
`
`gene in human solid tumor cell lines. Cancer Res. 52: 2460-2463,
`
`1992. PubMed: 1568216
`
`Giard DJ, et al. In vitro cultivation of human tumors:
`establishment of cell lines derived from a series of solid tumors. J.
`Natl. Cancer Inst. 51: 1417-1423 , 1973, PubMed: 4357758
`
`Fogh J. Cultivation, characterization, and identification of human
`tumor cells witt, emµhasis on kidney, testis, and bladder tumors.
`
`Natl. Cancer Inst. Monogr. 4fJ· fj.,9, 1978. PubMe,J: 571047
`
`https://www.atcc.org/Products/AII/HTB-44.aspx?&p=1&rel=documentation#documentation
`
`1/1
`
`Breckenridge Exhibit 1156
`Breckenridge v. Novartis IPR2017-01592
`HTB-44-A498
`Page 6
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
